United Health Products, Inc. (UEEC) stock
UEECOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.04−0.01 (-23.53%)
Close on Oct 19, 2026Market cap $10.25MP/E –Yield –
United Health Products r&d expenses
Research and development expenses are spending on new products and technology.
United Health Products's R&D Expenses for the twelve months ending Sep 30, 2026 was $48.06K, down 86.0% year over year. For fiscal 2025 it was $269.87K, down 24.2% from the year before. The highest annual figure on record is $666.39K in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $269.87K | -24.2% |
| FY2024 | Dec 31, 2024 | $355.94K | -40.6% |
| FY2023 | Dec 31, 2023 | $598.81K | -4.1% |
| FY2022 | Dec 31, 2022 | $624.56K | +163.0% |
| FY2021 | Dec 31, 2021 | $237.46K | -3.2% |
| FY2020 | Dec 31, 2020 | $245.22K | -63.2% |
| FY2019 | Dec 31, 2019 | $666.39K | +766.0% |
| FY2018 | Dec 31, 2018 | $76.95K | +286.0% |
| FY2017 | Dec 31, 2017 | $19.94K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.68K | -92.6% |
| Q2 FY2026 | Jun 30, 2026 | $3.85K | -95.2% |
| Q1 FY2026 | Mar 31, 2026 | $12.56K | -89.2% |
| Q4 FY2025 | Dec 31, 2025 | $28.96K | -73.4% |
| Q3 FY2025 | Sep 30, 2025 | $36.20K | -45.1% |
| Q2 FY2025 | Jun 30, 2025 | $80.98K | +23.2% |
| Q1 FY2025 | Mar 31, 2025 | $116.25K | +0.6% |
| Q4 FY2024 | Dec 31, 2024 | $108.78K | -29.0% |
| Q3 FY2024 | Sep 30, 2024 | $65.89K | -45.9% |
| Q2 FY2024 | Jun 30, 2024 | $65.72K | -37.5% |
| Q1 FY2024 | Mar 31, 2024 | $115.55K | -47.2% |
| Q4 FY2023 | Dec 31, 2023 | $153.26K | -26.9% |
| Q3 FY2023 | Sep 30, 2023 | $121.76K | -43.4% |
| Q2 FY2023 | Jun 30, 2023 | $105.11K | -28.8% |
| Q1 FY2023 | Mar 31, 2023 | $218.68K | +317.7% |
| Q4 FY2022 | Dec 31, 2022 | $209.62K | +131.3% |
| Q3 FY2022 | Sep 30, 2022 | $214.98K | +988.1% |
| Q2 FY2022 | Jun 30, 2022 | $147.61K | +114.3% |
| Q1 FY2022 | Mar 31, 2022 | $52.36K | -10.0% |
| Q4 FY2021 | Dec 31, 2021 | $90.64K | -41.3% |
| Q3 FY2021 | Sep 30, 2021 | $19.76K | -67.1% |
| Q2 FY2021 | Jun 30, 2021 | $68.88K | +264.7% |
| Q1 FY2021 | Mar 31, 2021 | $58.18K | +393.6% |
| Q4 FY2020 | Dec 31, 2020 | $154.50K | -43.6% |
| Q3 FY2020 | Sep 30, 2020 | $60.04K | -60.0% |
| Q2 FY2020 | Jun 30, 2020 | $18.89K | -91.2% |
| Q1 FY2020 | Mar 31, 2020 | $11.79K | -57.0% |
| Q4 FY2019 | Dec 31, 2019 | $274.13K | – |
| Q3 FY2019 | Sep 30, 2019 | $149.99K | – |
| Q2 FY2019 | Jun 30, 2019 | $214.86K | – |
| Q1 FY2019 | Mar 31, 2019 | $27.41K | – |
See a number that looks wrong?